What are the differential diagnoses for Phimosis and Paraphimosis?

1. McGregor TB, Pike JG, Leonard MP. Pathologic and physiologic phimosis: approach to the phimotic foreskin. Can Fam Physician. 2007 Mar. 53(3):445-8. [Medline].

2. Tews M, Singer JI. Paraphimosis: Definition, pathophysiology, and clinical features. www.utdol.com. 9/20/2008;

3. Sneppen I, Thorup J. Foreskin Morbidity in Uncircumcised Males. Pediatrics. 2016 May. 137 (5):[Medline].

4. Dubin J, Davis JE. Penile emergencies. Emerg Med Clin North Am. 2011 Aug. 29(3):485-99. [Medline].

5. Drake T, Rustom J, Davies M. Phimosis in childhood. BMJ. 2013 Jun 20. 346:f3678. [Medline].

6. Flores S, Herring AA. Ultrasound-guided dorsal penile nerve block for ED paraphimosis reduction. Am J Emerg Med. 2015 Jun. 33 (6):863.e3-5. [Medline].

7. Khan A, Riaz A, Rogawski KM. Reduction of paraphimosis in children: the EMLA® glove technique. Ann R Coll Surg Engl. 2014 Mar. 96 (2):168. [Medline].

8. Pohlman GD, Phillips JM, Wilcox DT. Simple method of paraphimosis reduction revisited: point of technique and review of the literature. J Pediatr Urol. 2013 Feb. 9 (1):104-7. [Medline].

9. Vorilhon P, Martin C, Pereira B, Clément G, Gerbaud L. [Assessment of topical steroid treatment for childhood phimosis: review of the literature]. Arch Pediatr. 2011 Apr. 18(4):426-31. [Medline].

10. Palmer LS, Palmer JS. The efficacy of topical betamethasone for treating phimosis: a comparison of two treatment regimens. Urology. 2008 Jul. 72(1):68-71. [Medline].

11. Nascimento FJ, Pereira RF, Silva JL 2nd, Tavares A, Pompeo AC. Topical betamethasone and hyaluronidase in the treatment of phimosis in boys: a double-blind, randomized, placebo-controlled trial. Int Braz J Urol. 2011 May-Jun. 37(3):314-9. [Medline].

12. Anand A, Kapoor S. Mannitol for paraphimosis reduction. Urol Int. 2013. 90(1):106-8. [Medline].

13. Pedersini P, Parolini F, Bulotta AL, Alberti D. "Trident" preputial plasty for phimosis in childhood. J Pediatr Urol. 2017 Jun. 13 (3):278.e1-278.e4. [Medline].

14. Burstein B, Paquin R. Comparison of outcomes for pediatric paraphimosis reduction using topical anesthetic versus intravenous procedural sedation. Am J Emerg Med. 2017 Apr 11. [Medline].

15. Monarca C, Rizzo MI, Quadrini L, Sanese G, Prezzemoli G, Scuderi N. Prepuce-sparing plasty and simple running suture for phimosis. G Chir. 2013 Jan-Feb. 34 (1-2):38-41. [Medline].

16. Moreno G, Corbalán J, Peñaloza B, Pantoja T. Topical corticosteroids for treating phimosis in boys. Cochrane Database Syst Rev. 2014 Sep 2. CD008973. [Medline].

17. Siev M, Keheila M, Motamedinia P, Smith A. Indications for adult circumcision: a contemporary analysis. Can J Urol. 2016 Apr. 23 (2):8204-8. [Medline].

18. Lundquist ST, Stack LB. Diseases of the foreskin, penis, and urethra. Emerg Med Clin North Am. 2001 Aug. 19(3):529-46. [Medline].

19. Castagnetti M, Leonard M, Guerra L, Esposito C, Cimador M. Benign penile skin anomalies in children: a primer for pediatricians. World J Pediatr. 2015 Mar 9. [Medline].

20. Raman SR, Kate V, Ananthakrishnan N. Coital paraphimosis causing penile necrosis. Emerg Med J. 2008 Jul. 25(7):454. [Medline].

21. Kessler CS, Bauml J. Non-traumatic urologic emergencies in men: a clinical review. West J Emerg Med. 2009 Nov. 10(4):281-7. [Medline].

22. Choe JM. Paraphimosis: current treatment options. Am Fam Physician. 2000 Dec 15. 62(12):2623-6, 2628. [Medline].

23. Little B, White M. Treatment options for paraphimosis. Int J Clin Pract. 2005 May. 59(5):591-3. [Medline].

24. Afonso LA, Cordeiro TI, Carestiato FN, Ornellas AA, Alves G, Cavalcanti SM. High Risk Human Papillomavirus Infection of the Foreskin in Asymptomatic Men and Patients with Phimosis. J Urol. 2016 Jun. 195 (6):1784-9. [Medline].

25. Huang YC, Huang YK, Chen CS, Shindel AW, Wu CF, Lin JH, et al. Phimosis with Preputial Fissures as a Predictor of Undiagnosed Type 2 Diabetes in Adults. Acta Derm Venereol. 2016 Mar 1. 96 (3):377-80. [Medline].

26. Nobre YD, Freitas RG, Felizardo MJ, Ortiz V, Macedo A Jr. To circ or not to circ: clinical and pharmacoeconomic outcomes of a prospective trial of topical steroid versus primary circumcision. Int Braz J Urol. 2010 Jan-Feb. 36(1):75-85. [Medline].

27. O'Donnell, JA II. Phimosis and paraphimosis. Barkin RM, et al, eds. Pediatric Emergency Medicine. 2nd ed. St Louis, Mo: Mosby; 1997. 1152-3.

28. DeVries CR, Miller AK, Packer MG. Reduction of paraphimosis with hyaluronidase. Urology. 1996 Sep. 48(3):464-5. [Medline].

29. Gairdner D. The fate of the foreskin, a study of circumcision. Br Med J. 1949 Dec 24. 2(4642):1433-7, illust. [Medline].

30. Green M, Stange GR. Paraphimosis reduction. Henretig FM, King C, eds. Textbook of Pediatric Emergency Procedures. Baltimore, Md: 1997. 1007-10.

31. Hamdy FC, Hastie KJ. Treatment for paraphimosis: the 'puncture' technique. Br J Surg. 1990 Oct. 77(10):1186. [Medline].

32. Hayashi Y, Kojima Y, Mizuno K, Kohri K. Prepuce: phimosis, paraphimosis, and circumcision. ScientificWorldJournal. 2011 Feb 3. 11:289-301. [Medline].

33. Litzky GM. Reduction of paraphimosis with hyaluronidase. Urology. 1997 Jul. 50(1):160. [Medline].

34. Monsour MA, Rabinovitch HH, Dean GE. Medical management of phimosis in children: our experience with topical steroids. J Urol. 1999 Sep. 162(3 Pt 2):1162-4. [Medline].

35. Treatment of Paraphimosis. Available at https://forum.doctissimo.fr/doctissimo/Prepuce-et-phimosis/cicatrice-operation-sujet_301_1.htm. Accessed: October 21, 2008.

36. Waseem M, Devas G. Photo Quiz. Resident and Staff Physician. June 2007. 53(6):[Full Text].

Hina Z Ghory, MD Associate Physician, Department of Emergency Medicine, Robert Wood Johnson University Hospital at Hamilton

Hina Z Ghory, MD is a member of the following medical societies: American College of Emergency Physicians, Phi Beta Kappa

Disclosure: Nothing to disclose.

Rahul Sharma, MD, MBA, FACEP Medical Director and Associate Chief of Service, NYU Langone Medical Center, Tisch Hospital Emergency Department; Assistant Professor of Emergency Medicine, New York University School of Medicine

Rahul Sharma, MD, MBA, FACEP is a member of the following medical societies: American College of Emergency Physicians, American Association for Physician Leadership, Phi Beta Kappa, Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Richard H Sinert, DO Professor of Emergency Medicine, Clinical Assistant Professor of Medicine, Research Director, State University of New York College of Medicine; Consulting Staff, Vice-Chair in Charge of Research, Department of Emergency Medicine, Kings County Hospital Center

Richard H Sinert, DO is a member of the following medical societies: American College of Physicians, Society for Academic Emergency Medicine

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Pfizer Pharmaceutical<br/>Received research grant from: National Institutes Health.

Gil Z Shlamovitz, MD, FACEP Associate Professor of Clinical Emergency Medicine, Keck School of Medicine of the University of Southern California; Chief Medical Information Officer, Keck Medicine of USC

Gil Z Shlamovitz, MD, FACEP is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association

Disclosure: Nothing to disclose.

Jerry R Balentine, DO, FACEP, FACOEP Vice President, Medical Affairs and Global Health, New York Institute of Technology; Professor of Emergency Medicine, New York Institute of Technology College of Osteopathic Medicine

Jerry R Balentine, DO, FACEP, FACOEP is a member of the following medical societies: American College of Emergency Physicians, New York Academy of Medicine, American College of Osteopathic Emergency Physicians, American Association for Physician Leadership, American Osteopathic Association

Disclosure: Nothing to disclose.